News
06-03-2011, 09:31 PM
Nuvera Biosciences, a molecular diagnostics company that develops gene-based diagnostic assays for personalized medicine in cancer, announced the results of a blinded validation study on its breast cancer assay for taxane chemotherapy response.
More... (http://www.news-medical.net/news/20110604/Nuvera-announces-results-of-blinded-study-on-breast-cancer-assay-for-taxane-chemotherapy-response.aspx)
More... (http://www.news-medical.net/news/20110604/Nuvera-announces-results-of-blinded-study-on-breast-cancer-assay-for-taxane-chemotherapy-response.aspx)